Amgen Lifts Outlook on Strong Drug Sales, to End Early Development of Obesity Treatment - WSJ
Amgen Lifts Outlook on Strong Drug Sales, to End Early Development of Obesity Treatment WSJ
Amgen Company News
Amgen Stock Climbs as Drug Growth Outruns Obesity Setback - Yahoo Finance
Amgen Stock Climbs as Drug Growth Outruns Obesity Setback Yahoo Finance
Amgen drops ph. 1 obesity drug, upping pressure on MariTide - Fierce Biotech
Amgen drops ph. 1 obesity drug, upping pressure on MariTide Fierce Biotech
AMGEN REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS - PR Newswire
AMGEN REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS PR Newswire
Amgen remains bullish on Repatha, axes obesity asset in 2Q report - FirstWord Pharma
Amgen remains bullish on Repatha, axes obesity asset in 2Q report FirstWord Pharma
Amgen raises 2026 EPS, revenue guidance as Q2 beats on both lines (AMGN:NASDAQ) - Seeking Alpha
Amgen raises 2026 EPS, revenue guidance as Q2 beats on both lines (AMGN:NASDAQ) Seeking Alpha
Amgen gains after strong quarterly results and continued product momentum - Yahoo Finance
Amgen gains after strong quarterly results and continued product momentum Yahoo Finance
Amgen rides Repatha renaissance as cardio wins keep cholesterol med's momentum rolling - Fierce Pharma
Amgen rides Repatha renaissance as cardio wins keep cholesterol med's momentum rolling Fierce Pharma
Animal activists rally outside Amgen's Thousand Oaks headquarters - Ventura County Star
Animal activists rally outside Amgen's Thousand Oaks headquarters Ventura County Star
Pfizer, Merck, Amgen Double Down On Cancer And Send Takeover Buzz Around SLS And IBRX Into Overdrive - Stocktwits
Pfizer, Merck, Amgen Double Down On Cancer And Send Takeover Buzz Around SLS And IBRX Into Overdrive Stocktwits
Highlights from Amgen's 2026 Second Quarter Earnings Report - Amgen
Highlights from Amgen's 2026 Second Quarter Earnings Report Amgen
Drug giant spends millions buying Wake County land for billion-dollar expansion - The Business Journals
Drug giant spends millions buying Wake County land for billion-dollar expansion The Business Journals
AmGen Announces Cyberattack and Data Breach Involving Patient Data - The HIPAA Journal
AmGen Announces Cyberattack and Data Breach Involving Patient Data The HIPAA Journal
Amgen says patient data, IP stolen in cybersecurity breach - Fierce Pharma
Amgen says patient data, IP stolen in cybersecurity breach Fierce Pharma
Animal rights activists target Amgen over research supplier - Thousand Oaks Acorn
Animal rights activists target Amgen over research supplier Thousand Oaks Acorn
Amgen contends with data breach, exposing patient information - Pharmaceutical Technology
Amgen contends with data breach, exposing patient information Pharmaceutical Technology
Amgen Inc (AMGN) (Q2 2026) Earnings Call Highlights: Revenue Surges Past $10 Billion, Guidance ... - Yahoo Finance
Amgen Inc (AMGN) (Q2 2026) Earnings Call Highlights: Revenue Surges Past $10 Billion, Guidance ... Yahoo Finance
Why Amgen (AMGN) Stock Is Trading Up Today - StockStory
Why Amgen (AMGN) Stock Is Trading Up Today StockStory
Amgen hit with cybersecurity breach, patient data affected - BioSpace
Amgen hit with cybersecurity breach, patient data affected BioSpace
California drugmaker Amgen reports theft of patient data in cyber incident - The Mercury News
California drugmaker Amgen reports theft of patient data in cyber incident The Mercury News
Biotech giant Amgen says patient data stolen from third-party cloud systems - The Record from Recorded Future News
Biotech giant Amgen says patient data stolen from third-party cloud systems The Record from Recorded Future News
Amgen discloses data breach involving patient health information - Reuters
Amgen discloses data breach involving patient health information Reuters
Amgen Inc. Cloud Data Breach Exposes Patient PHI in 2026 Cybersecurity Incident Analysis - Rescana
Amgen Inc. Cloud Data Breach Exposes Patient PHI in 2026 Cybersecurity Incident Analysis Rescana
Amgen’s MariTide stands alone after obesity cull while analysts seek more M&A - BioSpace
Amgen’s MariTide stands alone after obesity cull while analysts seek more M&A BioSpace
Amgen (NASDAQ:AMGN) Delivers Strong Q2 CY2026 Numbers, Guides for Strong Full-Year Sales - StockStory
Amgen (NASDAQ:AMGN) Delivers Strong Q2 CY2026 Numbers, Guides for Strong Full-Year Sales StockStory
PRIVACY ALERT: Amgen Under Investigation for Data Breach of Records - Schubert Jonckheer & Kolbe
PRIVACY ALERT: Amgen Under Investigation for Data Breach of Records Schubert Jonckheer & Kolbe
Amgen second-quarter sales rise 9%, profit tops Street view - Reuters
Amgen second-quarter sales rise 9%, profit tops Street view Reuters
Amgen Q2 Earnings Call Highlights - TradingView
Amgen Q2 Earnings Call Highlights TradingView
Trilogy Capital Inc. Has $302,000 Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Trilogy Capital Inc. Has $302,000 Stock Holdings in Amgen Inc. $AMGN MarketBeat
Amgen Inc. stock outperforms competitors on strong trading day - MarketWatch
Amgen Inc. stock outperforms competitors on strong trading day MarketWatch
Amgen gains after strong quarterly results and continued product momentum - Proactive financial news
Amgen gains after strong quarterly results and continued product momentum Proactive financial news
Amgen (AMGN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Amgen (AMGN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates Yahoo Finance
Amgen (AMGN) Faces Patient Data Breach And Tavneos Review Risk - Yahoo Finance
Amgen (AMGN) Faces Patient Data Breach And Tavneos Review Risk Yahoo Finance
Amgen says hackers stole patient data in cloud breach - Endpoints News
Amgen says hackers stole patient data in cloud breach Endpoints News
Amgen Earnings: Broad-Based Growth Despite Prolia Biosimilars; Maintaining Our Fair Value - Morningstar
Amgen Earnings: Broad-Based Growth Despite Prolia Biosimilars; Maintaining Our Fair Value Morningstar
Final Trades: Amgen, Chubb and Toast - CNBC
Final Trades: Amgen, Chubb and Toast CNBC
Amgen Inc Stock (AMGN) Moved Up by 4.57% on Aug 5: Drivers Behind the Movement - TradingKey
Amgen Inc Stock (AMGN) Moved Up by 4.57% on Aug 5: Drivers Behind the Movement TradingKey
Amgen (AMGN) Stock Jumps As Raised Guidance Meets Mounting Risks - simplywall.st
Amgen (AMGN) Stock Jumps As Raised Guidance Meets Mounting Risks simplywall.st
Amgen's Cardiometabolic Pipeline Is Likely to Build on Repatha and Further Support Its Wide Moat - Morningstar
Amgen's Cardiometabolic Pipeline Is Likely to Build on Repatha and Further Support Its Wide Moat Morningstar
Amgen stock hits all-time high at 398.65 USD - Investing.com
Amgen stock hits all-time high at 398.65 USD Investing.com